SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

A Wells Fargo analyst downgrade to Underweight is driving the attention and sharp selling in Netflix, with traders also debating the conflicting bullish Evercore view. The community is split between bearish concerns about slowing growth, valuation and persistent weakness, and buyers citing advertising growth, buybacks, live sports and strong earnings as reasons to accumulate the dip.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs full FDA approval of Fayuvi, the first treatment for Sanfilippo syndrome type A, is driving attention, with traders highlighting the new commercial opportunity and accompanying Priority Review Voucher. The community is broadly bullish but debates whether the stocks muted reaction reflects limited patient numbers, commercialization and cash-burn concerns, or potential short-covering and further institutional interest.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp NEAR rally is driving momentum and short-squeeze speculation, with bullish traders highlighting the tokens AI, chain-abstraction and NEAR Intents utility. Skeptics argue the move is largely liquidity- or whale-driven and warn that it may be a pump without a clear catalyst.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A reported but unverified plan for AMD to raise prices on some AI accelerators and graphics products, attributed to higher TSMC wafer costs, is adding to a broader AI-chip rebound. Traders are largely bullish on momentum, short-squeeze and call activity, while some warn the move is overextended and vulnerable to profit-taking.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of HLP003s Phase 3 readout is driving attention, reinforced by completed enrollment, conference commentary from the new CEO, and reported insider buying. Traders are bullish on the drugs earlier efficacy signals and potential psychedelic-sector re-rating, while skeptics cite clinical-stage uncertainty and future dilution risk.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Anticipation of a long-delayed Judge Andrews ruling in Liquidias patent litigation with United Therapeutics is driving attention, with traders treating the decision as a binary catalyst and debating whether it will clear YUTREPIAs legal overhang or create downside risk. The discussion also cites continued YUTREPIA adoption and commercial growth, though some traders view the recent strength as overextended and favor puts or profit-taking while the ruling remains unresolved.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswaps reported Robinhood Chain integration and activated fee-switch/buyback-and-burn narrative are driving attention, with traders viewing potential tokenized-asset volume and reduced supply as bullish. The community remains divided, as some expect further momentum while others flag overbought conditions, profit-taking, and possible pullbacks.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Strong Q2 results, improved margins, raised guidance, and the expansion of Velo3Ds Livermore production campus have fueled attention, with traders viewing accelerating aerospace and defense demand as a potential growth catalyst. The community remains divided between bullish momentum and short-squeeze expectations versus concerns about profitability, contract visibility, accounting, and the stocks volatile post-earnings reaction.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs plans to expand Starlink into a full mobile network are driving attention, with traders debating whether the service could take meaningful wireless customers from AT&T or remains a long-term, capital-intensive threat. Bullish participants point to AT&Ts strong wireless and fiber additions, cash flow, buybacks and satellite partnerships as offsets, while others remain concerned about intensified telecom competition.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Speculation about a potential pharmaceutical buyout is driving attention, supported by Vandas NEREUS launch, planned BYSANTI rollout and late-stage pipeline, particularly the GLP-1-related nausea program. Traders are divided, with bullish participants emphasizing pipeline and acquisition value while skeptics focus on heavy marketing spending, cash burn, payer access and management execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RKLB, ASTS, VOYG, LUNR Steal SpaceX’s Thunder — Here’s What Lit Up Space Stocks This Week

Rocket Labs completed equity offering fully funds its planned Iridium acquisition and removes the associated bridge financing, while the deal remains subject to shareholder and regulatory approvals. Traders are broadly bullish on the reduced financing overhang and ongoing Neutron hardware progress, though bears cite dilution, valuation, macro pressure, and launch-delay risks.

RKLB Stock Eyes Best Week In Over A Month: Rocket Lab Tests Key Neutron Hardware To Take On SpaceX

The move appears tied primarily to Rocket Labs Neutron development milestones, including pre-flight testing of its reusable Hungry Hippo fairing and installation of a 10-meter second-stage test stand in Virginia. Traders are also focusing on the FCC accepting the Iridium license-transfer applications for filing, which opened the public-comment process for the proposed acquisition.

Equity

Rocket Lab raised $1.944 billion for its $8 billion Iridium acquisition, while advancing Neutron hardware testing in Virginia.

SpaceX or Rocket Lab: Which Space Stock Is the Better Buy for the Next Decade?

Key PointsSpaceX has an ambitious plan to grow into space applications and AI infrastructure in orbit...

SpaceX’s reported decision to restrict new Falcon 9 commercial bookings beyond 2028 could create an opening for Neutron as Starship takes over future traffic.

SpaceX Adds $100B in One DayThat's More Than Two Rocket Labs

SpaceX gains $100 billion to reach a $2 trillion market cap on Starship launch hopes, dwarfing Rocket Lab amid volatility and lockup risks.read more...

Satellites Built Today Must Outlive the Encryption Protecting Them

Satellites Built Today Must Outlive the Encryption Protecting Them Satellites Built Today Must Outlive the Encryption Protecting ThemPR NewswireVANCOUVER, BC, Sept. 17, 2026 VANCOUVER, BC, Sept. 17, 2026 /PRNewswire/ -- Equity Insider News Commentary A satellite launched this year may still be...

RKLB Stock Eyes Ending 5-Week Slide: Iridium Deal Clears First FCC Hurdle, VC Backer Hails Solar Breakthrough

Iridium shareholders will vote Sept.24 on the $8.1 billion deal, which is expected to close in mid-2027.

Can Rocket Lab's Component Portfolio Support Space Market Growth?

RKLB expands its spacecraft component business with avionics, radios and batteries, extending its role across the space supply chain.

RKLB, ASTS, SPCX, RDW Stocks Set For A Boost? Pentagon Confirms Orbital Weapons Use, Ramps Up Golden Dome Plans 

Golden Dome’s space-based interceptor program reached “flight-ready hardware,” with an integrated demonstration targeted for 2028.

Rocket Lab Corporation (RKLB) Advances While Market Declines: Some Information for Investors

Rocket Lab Corporation (RKLB) closed at $63.55 in the latest trading session, marking a +1.6% move from the prior day.

Rocket Lab Secures Funding for Iridium Buyout

Rocket Lab completes a $1.94B stock offering to buy Iridium, cancels a $3.6B loan facility, and retains Iridium's debt structure.read more...

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Bullish Sentiment

Rocket Lab (RKLB) stock price today, news, financials, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

RKLB - Rocket Lab Stock Price Today, News, Analysis and Trading Ideas

SpaceX is one of the most anticipated IPOs in recent history. Its booming business across the space industry has created tremendous hype, but hype doesn't always translate to outperformance. Do you think SpaceX will outperform the S&P 500 over the next five years?

Do you think SpaceX ($SPCX) will outperform the S&amp;P 500 ($SPY) over the next 5 years?

Stocktwits

SpaceX

Stocktwits Polls

Rocket Lab USA Inc

Investors are optimistic about the upcoming Iridium acquisition and the completed funding phase potentially clearing the way for higher share prices.

Enthusiastic chatter surrounds the ongoing hardware testing for the new launch vehicle as it prepares to compete in the space sector.

Traders are actively debating aggressive price targets between $80 and $175, with many bulls expecting a breakout as momentum builds.

High tension between vocal bulls and short-selling bears is defining current price action as traders debate whether current levels are a trap or a bottom.

Feed

News

Sentiment

Earnings

Fundamentals

Info

RKLB Rocket Lab USA Inc

Fundamentals

Latest RKLB News